Cite
HARVARD Citation
Avvakumova, S. et al. (2019). Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells. Nanoscale advances. 1 (9), pp. 3626-3638. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Avvakumova, S. et al. (2019). Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells. Nanoscale advances. 1 (9), pp. 3626-3638. [Online].